The outcome of prostatic cancer treated with estrogens
Claereboudt, E.; Vanwelkenhuyzen, P.
Acta Urologica Belgica 41(3): 427-431
1973
ISSN/ISBN: 0001-7183 PMID: 4751698 Document Number: 65235
Document emailed within 1 workday
Related Documents
Sciarra, F.; Sorcini, G.; Di Silverio, F.; Gagliardi, V. 1970: In vitro biosynthesis of androgens in testis of subjects with prostatic cancer treated with estrogens and cyproterone acetate Folia Endocrinologica 23(3): 264-277Gayet, R.; Curtillet, H. 1974: Regression of pulmonary metastases from prostatic cancer after treatment with estrogens Journal d'Urologie et de Nephrologie 80(7-8): 709-715
Narayan, J.P.; Srivastava, S.P.; Singh, J.N. 1985: Free estrogens and progestogens in benign prostatic hypertrophy Indian Journal of Physiology and Pharmacology 29(2): 119-122
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Adding, C.; Nilsson, A.; Carlsson, S.; Wiklund, P.; Nyberg, T.; Steineck, G. 2011: Good results in robot-assisted radical prostatectomy. Prostatic cancer can be treated more effectively and carefully Lakartidningen 108(19): 1053-1057
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
De Voogt, H.J.; Adenauer, H.; Widdra, W.G. 1991: The use of the LHRH-analogue Buserelin in the treatment of prostatic cancer. a 10-year review on 1522 patients treated in 119 centres on 4 continents Scandinavian Journal of Urology and Nephrology. Supplementum 138: 131-136
Abdalla, I.; Thisted, R.A.; Heimann, R. 2000: The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy Cancer Journal 6(4): 266-272
Leńko, J.; Marczyńska, A.; Kulpa, J.; Kwinta, A.; Bugajski, A. 1986: Biochemical control investigations (determinations of prostatic phosphatase--carcinoembryonic antigen alkaline phosphatase) in patients treated for prostatic carcinoma. Preliminary estimation of effectiveness Materia Medica Polona. Polish Journal of Medicine and Pharmacy 18(4): 238-243
Rodríguez Rodríguez, R.; Mayayo Dehesa, T.; Galbis Sanjuan, F.; Burgos Revilla, F.J.; Jiménez Cidre, M.; García González, R. 1996: Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 49(7): 669-673
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Hembree, W.; Dyrenfurth, I. 1985: Testicular estrogens during long term gonadotropin therapy for infertility relation to outcome Journal of Andrology 6(2 Suppl): 46-P
Teni, T.R.; Bandivdekar, A.H.; Sheth, A.R.; Sheth, N.A. 1989: Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay Clinical Chemistry 35(7): 1376-1379
Tural, D.; Selcukbiricik, F.; Erdamar, S.; Ozkurt, C.Unlu.; Yanmaz, T.; Mandel, N.Molinas.; Serdengeçti, Süheyla. 2013: Association KRAS G13D tumor mutated outcome in patients with chemotherapy refractory metastatic colorectal cancer treated with cetuximab Hepato-Gastroenterology 60(125): 1035-1040
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Lledó García, E.; Subirá Castillón, C.; González Chamorro, F.; Rodríguez Fernández, E. 1997: Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer Archivos Espanoles de Urologia 50(3): 253-258
Lowe, F.C.; Isaacs, J.T. 1984: Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model Cancer Research 44(2): 744-752
Cottone, G.; Laterza, G.; Gallo, G.; Re, M.; Ronchi, F.; Zappi, P.; Scibinetti, F.; Russo, G.; Amici, A.; Clemenzia, G. 1987: Changes in urinary NAG activity in patients with climacteric syndrome treated with estrogens Minerva Medica 78(6): 399-402